Disodium Ribonucleotides (I+G) Market Report – Research, Industry Analysis Reports and Market Demands

Global Disodium Ribonucleotides (I+G) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 GMP
- 1.3.3 IMP
- 1.3.4 I+G Type
1.4 Market Analysis by Production Process
- 1.4.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Production Process: 2021 Versus 2025 Versus 2032
- 1.4.2 Fermentation
- 1.4.3 Enzymatic Conversion
- 1.4.4 Semi-Synthesis
1.5 Market Analysis by Product Form
- 1.5.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Product Form: 2021 Versus 2025 Versus 2032
- 1.5.2 Powder
- 1.5.3 Granules
- 1.5.4 Crystals
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 MSG and Chicken Essence
- 1.6.3 Soy Sauce
- 1.6.4 Instant Noodle Seasoning Packet
- 1.6.5 Seasoning Compound Sauce
- 1.6.6 Others
1.7 Global Disodium Ribonucleotides (I+G) Market Size & Forecast
- 1.7.1 Global Disodium Ribonucleotides (I+G) Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Disodium Ribonucleotides (I+G) Sales Quantity (2021-2032)
- 1.7.3 Global Disodium Ribonucleotides (I+G) Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Disodium Ribonucleotides (I+G) by Manufacturer

3.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Disodium Ribonucleotides (I+G) Revenue by Manufacturer (2021-2026)
3.3 Global Disodium Ribonucleotides (I+G) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Disodium Ribonucleotides (I+G) by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Disodium Ribonucleotides (I+G) Manufacturer Market Share in 2025
- 3.4.3 Top 6 Disodium Ribonucleotides (I+G) Manufacturer Market Share in 2025
3.5 Disodium Ribonucleotides (I+G) Market: Overall Company Footprint Analysis
- 3.5.1 Disodium Ribonucleotides (I+G) Market: Region Footprint
- 3.5.2 Disodium Ribonucleotides (I+G) Market: Company Product Type Footprint
- 3.5.3 Disodium Ribonucleotides (I+G) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Disodium Ribonucleotides (I+G) Market Size by Region
- 4.1.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2032)
- 4.1.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2032)
- 4.1.3 Global Disodium Ribonucleotides (I+G) Average Price by Region (2021-2032)
4.2 North America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.3 Europe Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.4 Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.5 South America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.6 Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
5.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Type (2021-2032)
5.3 Global Disodium Ribonucleotides (I+G) Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
6.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Application (2021-2032)
6.3 Global Disodium Ribonucleotides (I+G) Average Price by Application (2021-2032)

7 North America

7.1 North America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
7.2 North America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
7.3 North America Disodium Ribonucleotides (I+G) Market Size by Country
- 7.3.1 North America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
- 7.3.2 North America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
8.2 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
8.3 Europe Disodium Ribonucleotides (I+G) Market Size by Country
- 8.3.1 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Disodium Ribonucleotides (I+G) Market Size by Region
- 9.3.1 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
10.2 South America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
10.3 South America Disodium Ribonucleotides (I+G) Market Size by Country
- 10.3.1 South America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
- 10.3.2 South America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Disodium Ribonucleotides (I+G) Market Size by Country
- 11.3.1 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Disodium Ribonucleotides (I+G) Market Drivers
12.2 Disodium Ribonucleotides (I+G) Market Restraints
12.3 Disodium Ribonucleotides (I+G) Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Disodium Ribonucleotides (I+G) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Disodium Ribonucleotides (I+G)
13.3 Disodium Ribonucleotides (I+G) Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Disodium Ribonucleotides (I+G) Typical Distributors
14.3 Disodium Ribonucleotides (I+G) Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Disodium Ribonucleotides (I+G) market size was valued at US$ 636 million in 2025 and is forecast to a readjusted size of US$ 798 million by 2032 with a CAGR of 3.5% during review period.
Disodium Ribonucleotides (I+G), commonly known as I+G, is a high-efficiency flavor enhancer composed mainly of disodium inosinate (IMP) and disodium guanylate (GMP). It enhances umami taste by synergistically interacting with monosodium glutamate (MSG), providing stronger flavor intensity with lower usage levels. Disodium Ribonucleotides (I+G) is widely used in food seasoning applications, including MSG and chicken essence, soy sauce, instant noodle seasoning packets, compound seasoning sauces, and other processed food products. This research focuses on Disodium Ribonucleotides (I+G) products with different composition structures, including GMP, IMP, and I+G blended products, covering their production, supply, and application across the global food ingredient market.
Key Findings
Global Disodium Ribonucleotides (I+G) sales reached 75,006 MT in 2025
Average market price reached US$8,245 per MT in 2025
China accounted for 54.10% of global market demand in 2025
Southeast Asia represented 31.66% of global market demand
Top five players accounted for 91.09% of global revenue
Market Trends
The Disodium Ribonucleotides (I+G) industry is moving from a technology introduction stage toward refined operation and global competition. Demand is increasingly influenced by changes in food consumption patterns, including the expansion of ready-to-eat meals, snacks, plant-based foods, and convenience food products. Food manufacturers are also paying greater attention to flavor optimization, sodium reduction solutions, and clean-label product development, which is supporting the continued adoption of Disodium Ribonucleotides (I+G) as an efficient umami enhancer. At the same time, manufacturers are strengthening production efficiency, quality consistency, and customized formulation capabilities to improve competitiveness in a mature market.
Market Dynamics
Drivers
The growth of Disodium Ribonucleotides (I+G) demand is primarily driven by the expansion of processed food consumption, increasing penetration of global chain restaurants, and rising demand for convenient food products. The growth of ready-to-eat meals, instant food, snacks, and compound seasonings continues to create stable application opportunities. In addition, consumers’ preference for reduced-sodium foods without sacrificing taste is strengthening the strategic importance of Disodium Ribonucleotides (I+G), as it can enhance umami intensity and support lower salt formulations.
Restraints
The Disodium Ribonucleotides (I+G) market faces limitations from its relatively mature application structure and high dependence on downstream seasoning industries. Although demand remains stable, market expansion is closely linked to the growth rate of processed foods and foodservice sectors. In addition, strict food safety requirements, quality consistency standards, and production technology barriers increase operational requirements for manufacturers.
Opportunities
Emerging markets, particularly Southeast Asia and Africa, provide additional growth opportunities due to increasing per capita condiment consumption and expansion of processed food industries. The continued development of ready-to-eat meals, plant-based foods, and premium seasoning products creates new application scenarios for Disodium Ribonucleotides (I+G).
Challenges
The Disodium Ribonucleotides (I+G) industry faces challenges from high market concentration, intensified competition among leading producers, and pressure to maintain cost competitiveness. As China has become the global production center with more than 70% of global I+G production capacity, competition is increasingly focused on production efficiency, supply chain advantages, and pricing strategies.
Industry Chain Analysis
The Disodium Ribonucleotides (I+G) industry chain consists of upstream raw materials, fermentation-based manufacturing, and downstream food applications. Upstream production mainly relies on agricultural and biological raw materials required for fermentation processes, while midstream manufacturers use microbial fermentation, extraction, purification, and blending technologies to produce GMP, IMP, and I+G products. Production efficiency, fermentation technology, quality control, and scale advantages determine cost competitiveness.
Segment Insights
The Disodium Ribonucleotides (I+G) market is mainly segmented by product type and application. I+G blended products represent the mainstream commercial form due to their strong synergistic umami enhancement effect when combined with MSG. GMP and IMP products serve as important raw materials for customized formulations and specific applications.
Downstream Market Opportunities
The downstream market for Disodium Ribonucleotides (I+G) is closely connected with the global food processing and seasoning industries. Traditional applications such as MSG, chicken essence, soy sauce, and instant noodle seasoning remain stable demand bases, while emerging categories including ready-to-eat meals, snacks, plant-based foods, and premium sauces are expanding application opportunities.
Competitive Landscape Analysis
The global Disodium Ribonucleotides (I+G) market demonstrates a highly concentrated oligopolistic competitive structure. Major participants include CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, and Foison Biotechnology. In 2025, the top five players accounted for approximately 91.09% of global revenue, reflecting strong concentration among leading producers. China has become the core global supply base, supported by fermentation capabilities, production scale, and integrated industrial chains.
Report Scope
This report is a detailed and comprehensive analysis for global Disodium Ribonucleotides (I+G) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Disodium Ribonucleotides (I+G) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Disodium Ribonucleotides (I+G)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Disodium Ribonucleotides (I+G) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, Foison Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Disodium Ribonucleotides (I+G) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
GMP
IMP
I+G Type
Market segment by Production Process
Fermentation
Enzymatic Conversion
Semi-Synthesis
Market segment by Product Form
Powder
Granules
Crystals
Market segment by Application
MSG and Chicken Essence
Soy Sauce
Instant Noodle Seasoning Packet
Seasoning Compound Sauce
Others
Major players covered
CJ Group
Ajinomoto
Meihua Group
Star Lake Bioscience
Daesang
Foison Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Disodium Ribonucleotides (I+G) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Disodium Ribonucleotides (I+G), with price, sales quantity, revenue, and global market share of Disodium Ribonucleotides (I+G) from 2021 to 2026.
Chapter 3, the Disodium Ribonucleotides (I+G) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Disodium Ribonucleotides (I+G) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Disodium Ribonucleotides (I+G) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Disodium Ribonucleotides (I+G).
Chapter 14 and 15, to describe Disodium Ribonucleotides (I+G) sales channel, distributors, customers, research findings and conclusion.

Buy now